Molecular Insights into the Synergistic Anticancer and Oxidative Stress–Modulating Activity of Quercetin and Gemcitabine
Antioxidants · 10.01.2026 · 15 (1) · 91
DOI: 10.3390/antiox15010091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.01.2026. Verfasst von Yasemin Afşin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Private Batman Life Hospital, Batman 72060, Turkey. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Quercetin (Q), a bioactive flavonoid, exerts potent antioxidant and redox-modulating effects by activating the nuclear factor erythroid 2-related factor 2/antioxidant response Element (Nrf2/ARE) pathway and upregulating endogenous antioxidant defenses, including enzymatic antioxidants such as superoxide dismutase (SOD) and catalase (CAT), as well as non-enzymatic glutathione (GSH) and lipid peroxidation (MDA). Gemcitabine (Gem), a widely used antimetabolite chemotherapeutic, often shows limited efficacy under hypoxic and oxidative stress conditions driven by hypoxia-inducible factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF)-mediated angiogenesis. This study investigated the redox-mediated synergistic effects of Q and Gem in MDA-MB-231 human breast cancer cells. Combination treatment significantly reduced cell viability beyond the expected Bliss value, indicating a synergistic interaction and enhanced apoptosis compared with single-agent treatments. Increased reactive oxygen species (ROS) production was accompanied by depletion of GSH and accumulation of MDA, establishing a pro-apoptotic oxidative stress environment. Q alone enhanced SOD and CAT activities, whereas the combination induced exhaustion of antioxidant defenses under oxidative load, reflecting a redox-adaptive response. Molecular analyses revealed downregulation of HIF-1α and VEGF, alongside upregulation of Bax and Caspase-3, confirming suppression of hypoxia-driven survival and activation of the intrinsic apoptotic pathway. Transcriptomic and enrichment analyses further identified modulation of oxidative stress- and apoptosis-related pathways, including phosphoinositide-3-kinase–protein kinase B/Akt (PI3K/Akt), HIF-1 and VEGF signaling. Collectively, these results indicate that Q potentiates Gem cytotoxicity via redox modulation, promoting controlled ROS elevation and apoptosis while suppressing hypoxia-induced survival mechanisms, highlighting the therapeutic potential of redox-based combination strategies against chemoresistant breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Private Batman Life Hospital, Batman 72060, Turkey.
- Department of Gynecology and Obstetrics, Private Medical Practice, Bursa 16110, Turkey.
- Department of Histology Embryology, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş 46000, Turkey.
- Department of Anatomy, Faculty of Medicine, Dicle University, Diyarbakır 21200, Turkey.
- Vocational School of Health Services, Çanakkale Onsekiz Mart University, Çanakkale 17100, Turkey.
ORCID-Profile: Yasemin Afşin, Senem Alkan Akalın, İlhan Özdemir, Mehmet Cudi Tuncer, Şamil Öztürk
Zitieren
APA
Afşin, Y., Alkan Akalın, S., Özdemir, İ., Tuncer, M. C., & Öztürk, Ş. (2026). Molecular Insights into the Synergistic Anticancer and Oxidative Stress–Modulating Activity of Quercetin and Gemcitabine. Antioxidants, 15(1), 91. https://doi.org/10.3390/antiox15010091
Vancouver
Afşin Y, Alkan Akalın S, Özdemir İ, Tuncer MC, Öztürk Ş. Molecular Insights into the Synergistic Anticancer and Oxidative Stress–Modulating Activity of Quercetin and Gemcitabine. Antioxidants. 2026;15(1):91. doi:10.3390/antiox15010091
BibTeX
@article{Afin2026,
author = {Afşin, Yasemin and Alkan Akalın, Senem and Özdemir, İlhan and Tuncer, Mehmet Cudi and Öztürk, Şamil},
title = {Molecular Insights into the Synergistic Anticancer and Oxidative Stress–Modulating Activity of Quercetin and Gemcitabine},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {1},
pages = {91},
doi = {10.3390/antiox15010091}
}
EUVIMED